258 related articles for article (PubMed ID: 24194919)
1. High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India.
Andries A; Isaakidis P; Das M; Khan S; Paryani R; Desai C; Dalal A; Mansoor H; Verma R; Fernandes D; Sotgiu G; Migliori GB; Saranchuk P
PLoS One; 2013; 8(10):e78313. PubMed ID: 24194919
[TBL] [Abstract][Full Text] [Related]
2. Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.
Isaakidis P; Varghese B; Mansoor H; Cox HS; Ladomirska J; Saranchuk P; Da Silva E; Khan S; Paryani R; Udwadia Z; Migliori GB; Sotgiu G; Reid T
PLoS One; 2012; 7(7):e40781. PubMed ID: 22792406
[TBL] [Abstract][Full Text] [Related]
3. Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis.
Tola HH; Holakouie-Naieni K; Lejisa T; Mansournia MA; Yaseri M; Tesfaye E; Mola M
PLoS One; 2019; 14(6):e0218487. PubMed ID: 31211809
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.
Isaakidis P; Cox HS; Varghese B; Montaldo C; Da Silva E; Mansoor H; Ladomirska J; Sotgiu G; Migliori GB; Pontali E; Saranchuk P; Rodrigues C; Reid T
PLoS One; 2011; 6(12):e28066. PubMed ID: 22145022
[TBL] [Abstract][Full Text] [Related]
5. Ocular inflammatory disease and ocular tuberculosis in a cohort of patients co-infected with HIV and multidrug-resistant tuberculosis in Mumbai, India: a cross-sectional study.
Mehta S; Mansoor H; Khan S; Saranchuk P; Isaakidis P
BMC Infect Dis; 2013 May; 13():225. PubMed ID: 23687908
[TBL] [Abstract][Full Text] [Related]
6. Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.
Isaakidis P; Paryani R; Khan S; Mansoor H; Manglani M; Valiyakath A; Saranchuk P; Furin J
PLoS One; 2013; 8(7):e68869. PubMed ID: 23894358
[TBL] [Abstract][Full Text] [Related]
7. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
[TBL] [Abstract][Full Text] [Related]
8. High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho.
Satti H; Mafukidze A; Jooste PL; McLaughlin MM; Farmer PE; Seung KJ
Int J Tuberc Lung Dis; 2012 Apr; 16(4):468-72. PubMed ID: 22326109
[TBL] [Abstract][Full Text] [Related]
9. Abnormal thyroid function tests in children on ethionamide treatment.
Thee S; Zöllner EW; Willemse M; Hesseling AC; Magdorf K; Schaaf HS
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1191-3, i. PubMed ID: 21943844
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah T; Ncayiyana J; Padanilam X; Nyasulu PS
BMC Infect Dis; 2015 Oct; 15():478. PubMed ID: 26511616
[TBL] [Abstract][Full Text] [Related]
12. Thyroid function in multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen.
Ige OM; Akinlade KS; Rahamon SK; Edem VF; Arinola OG
Afr Health Sci; 2016 Jun; 16(2):596-602. PubMed ID: 27605977
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.
Mpagama SG; Heysell SK; Ndusilo ND; Kumburu HH; Lekule IA; Kisonga RM; Gratz J; Boeree MJ; Houpt ER; Kibiki GS
PLoS One; 2013; 8(5):e62034. PubMed ID: 23675411
[TBL] [Abstract][Full Text] [Related]
14. Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India.
Mehta S; Das M; Laxmeshwar C; Jonckheere S; Thi SS; Isaakidis P
PLoS One; 2016; 11(9):e0162138. PubMed ID: 27611434
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.
Smith JP; Gandhi NR; Shah NS; Mlisana K; Moodley P; Johnson BA; Allana S; Campbell A; Nelson KN; Master I; Brust JCM
J Acquir Immune Defic Syndr; 2020 Jan; 83(1):47-55. PubMed ID: 31809360
[TBL] [Abstract][Full Text] [Related]
16. 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis.
Isaakidis P; Rangan S; Pradhan A; Ladomirska J; Reid T; Kielmann K
Trop Med Int Health; 2013 Sep; 18(9):1128-1133. PubMed ID: 23837468
[TBL] [Abstract][Full Text] [Related]
17. Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
Sagwa EL; Ruswa N; Mavhunga F; Rennie T; Leufkens HG; Mantel-Teeuwisse AK
BMC Pharmacol Toxicol; 2015 Dec; 16():36. PubMed ID: 26654443
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.
Chem ED; Van Hout MC; Hope V
BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
